Community-Acquired Pneumonia: Updated Recommendations …
2020年7月15日 · Levofloxacin (Levaquin), 750 mg orally or IV every day or Moxifloxacin (Avelox), 400 mg orally or IV every day: Severe pneumonia without risk factors for MRSA or P. aeruginosa† Combination of:
Levofloxacin in the treatment of community-acquired pneumonia
Levofloxacin is a fluoroquinolone that has a broad spectrum of activity against several causative bacterial pathogens of community-acquired pneumonia (CAP). The efficacy and tolerability of levofloxacin 500 mg once daily for 10 days in patients with CAP are well established.
Levofloxacin - StatPearls - NCBI Bookshelf
2024年3月1日 · The recommended oral dose regimen is 750 mg daily to treat nosocomial pneumonia, complicated skin and skin structure infections (7 to 14 days), community-acquired pneumonia, acute bacterial sinusitis, complicated urinary tract infection (UTI), or acute pyelonephritis (5 days).
What Are the Best Antibiotics to Treat Pneumonia? - Verywell Health
2024年10月10日 · The best antibiotic to treat pneumonia will depend on several factors, such as your type of pneumonia, age, lifestyle, and medical history. Zithromax (azithromycin) is often the first-line treatment since it is effective against many different microbes that can cause pneumonia.
Diagnosis and Treatment of Adults with Community-acquired Pneumonia…
∘ respiratory fluoroquinolone (levofloxacin 750 mg daily, moxifloxacin 400 mg daily, or gemifloxacin 320 mg daily) (strong recommendation, moderate quality of evidence).
Fluoroquinolones for Respiratory Infections - CHEST
The newer fluoroquinolones provide more enhanced coverage for Gram-positive and atypical pathogens than ciprofloxacin, while the older ciprofloxacin provides greater efficacy for Pseudomonas species. 30 However, it is important to note that levofloxacin also provides very good coverage for Gram-positive and atypical infections, while ...
Treatment of community-acquired pneumonia in adults who …
2023年4月13日 · Community-acquired pneumonia (CAP) is defined as an acute infection of the pulmonary parenchyma in a patient who has acquired the infection in the community, as distinguished from hospital-acquired (nosocomial) pneumonia (HAP).
Treatment of community-acquired pneumonia in adults in the ... - UpToDate
2024年7月11日 · Community-acquired pneumonia (CAP) is defined as an acute infection of the pulmonary parenchyma in a patient who has acquired the infection in the community, as distinguished from hospital-acquired (nosocomial) pneumonia (HAP).
Fluoroquinolones for the Treatment of Respiratory Tract …
2019年5月6日 · This report aims to identify and synthesize the evidence describing the clinical effectiveness, cost-effectiveness, and evidence-based guidelines for the treatment of respiratory tract infections, including pneumonia and chronic obstructive pulmonary disease (COPD), using Fluoroquinolones.
Comparing Several Treatments with Antibiotics for Community …
Comparison of levofloxacin (L) and cefotaxime (C) combined with ofloxacin (O) for treatment of severe community-acquired pneumonia (CAP) in the intensive care unit. Crit Care, 8(Supplement 1):230. [ Google Scholar ]
- 某些结果已被删除